Skip to main content

INVO Fertility, Inc.

For the period ended Dec 31, 2024. Filed Apr 30, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Apr 30, 2025

IVF$2.35+9.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized on April 29, 2025.

INVO Fertility, Inc.
Date: April 29, 2025By:/s/ Steven Shum
Steven Shum
Chief Executive Officer (Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on April 29, 2025.

SignatureTitle
/s/ Steven ShumChief Executive Officer and director
Steven Shum(Principal Executive Officer)
/s/ Andrea GorenChief Financial Officer
Andrea Goren(Principal Financial and Accounting Officer)
/s/ Matthew Szot
Matthew SzotDirector
/s/ Trent Davis
Trent DavisDirector
/s/ Barbara Ryan
Barbara RyanDirector
/s/ Rebecca Messina
Rebecca MessinaDirector
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.